Introduction: Breast cancer survivors with secondary upper limb lymphoedema (ULL) may report a wide range of self-reported symptoms. At the moment, no overview of ULL-specific symptoms is available. The first aim, therefore, was to compare the prevalence rates of self-reported signs and symptoms in people with and without secondary ULL due to breast cancer treatment.
View Article and Find Full Text PDFPurpose: To ascertain how change in upper body lymphedema is assessed and understand how clinically significant change is determined.
Method: A systematic search of the literature resulted in 55 eligible studies for analysis.
Results: A range of assessment methods, measurement protocols, and outcomes were used in the literature.